Author: Errica Jensen

The silence surrounding Goss stock at the moment, the kind that descends after a heated argument is over and everyone realizes they still have to share a house, is more striking than the stock’s price. Gossamer Bio has been pushed into that awkward area of the market where “cheap” no longer means “bargain” but rather “damage” at about forty cents per share. It seems to me that traders are more concerned with fate than valuation when they discuss it. To put it simply, the story is a Phase 3 miss that fell into a quiet restaurant like a dropped tray.…

The chart of MP stock encourages more talking than is necessary. It ascended, descended, and ascended once more, acting more like a dispute over the future than a slumbering materials company. The first thing to realize is that MP Materials is not viewed by investors in the same manner as the majority of miners. They view it as they would a national project, a political mood ring, or a wager that the United States will no longer outsource the necessities of contemporary life. The company’s crown jewel, Mountain Pass, is not my romantic type. It is utilitarian, industrial, and sun-bleached—heavy…

Taking a moment to look away from the chart and visualize the store is the most honest way to understand HD stock. The expansive concrete aisles, the fluorescent lighting, and the scent of freshly cut lumber coming from the rear. It’s not exactly busy on a weekday afternoon, but it’s also rarely deserted—contractors moving flatbeds filled with plasterboard, a homeowner gazing at a wall of faucets for too long as though the choice would affect their financial situation. That same attitude pervaded Home Depot’s most recent quarter: stable, competent, and somewhat restrained. Comparable sales managed to slightly increase despite the…

Shortly after noon, the screens on the trading floor flashed green, and the CIFR stock was once again rising, rising more than 12% in a single session. Given the earnings report that had been released hours earlier, which showed revenue significantly below expectations and a quarterly EPS miss of $1.82, it was a strange sight. It looked ugly on paper. In reality, investors applauded. You can learn nearly everything there is to know about cipher mining at this time from that contradiction. Cipher was founded in 2021 and is based in New York. Its early identity was based on Bitcoin…

Zeta stock fell more than 8% in a single session, causing the trading screens inside a Midtown brokerage to flicker red on a gloomy February morning in Manhattan. It wasn’t exactly calm, but it also wasn’t panic. Leaning back in their chairs, traders read headlines about disruptions from artificial intelligence, wondering if the very technology Zeta advocates could eventually cause it to fail. One of those stocks that seems to exist in the liminal space between promise and proof is Zeta Global, a marketing technology company founded on customer data and automation driven by artificial intelligence. The stock, which is…

People tend to lean forward in their chairs when they are looking at ImmunityBio’s stock. It looks more than just a rally at about $11.55 per share, up more than 500% so far this year. It has the feel of a resurrection. IBRX was trading around $2 earlier this year, exhibiting the same level of skepticism and thin optimism as many small biotech hopefuls. The earnings release followed. $113 million in net product revenue for the entire year 2025. ANKTIVA, its immunotherapy for bladder cancer, is primarily responsible for the 700% annual increase. The volume of units sold reportedly increased…

The dramatic flair of Tesla and the algorithmic intensity of Nvidia are not reflected in the movement of Amazon’s stock. It moves in a unique way. heavier. more intentional. With a market valuation of over $2.2 trillion and a share price of about $209, Amazon is more like infrastructure than a trade—something that is ingrained in both portfolios and everyday life. Delivery vans, each filled to the brim with cardboard boxes bearing that recognizable curved arrow, rolled out of an industrial center just south of downtown Seattle on a recent weekday morning. Conveyor belts hummed, scanners beeped, and employees walked…

Even seasoned investors can become a little unsteady when they invest in Tesla stock. A week later, European sales data and legal headlines are pulling it down toward $350. The next day, it’s trading as if nothing had happened, back above $400. The company’s market value is more than $1.5 trillion as of this week, with shares trading at about $409. I still find that number unbelievable. Waiting for transport trucks, rows of recently assembled Model Ys sit baking in the Texas sun outside Tesla’s Gigafactory in Austin. Production is still going on. The equipment hums. However, the topic of…

At first glance, the Ares stock price doesn’t seem particularly dramatic. Although it is still far from the $195 peak it recently reached, it is currently trading at about $117, up slightly for the day and well above its 52-week low of $110. There is tension underneath that serene exterior, though. A subtle kind. Ares isn’t a glitzy tech star or a lightning rod for memes. In contrast to the glass towers of Manhattan finance, its Los Angeles headquarters almost seems understated. Ares, however, is ubiquitous in the world of private credit, where term sheets are being circulated, conference calls…

The stock of Apollo Global Management doesn’t move in silence. It surges, it hums, it stumbles every now and then, and when it does, the response seems out of proportion, almost theatrical. APO appears less unbeatable now than it did a few months ago, as it is down from highs of about $157 to about $114. However, it also doesn’t appear fragile. It appears to be adjusted. That is a significant difference. The corporate flash that Silicon Valley startups rely on is not visible if you walk past Apollo’s headquarters on West 57th Street in Manhattan. The building is elegant,…